🧫
Cytochrome Therapeutics
experiment
Created: 2026-04-02T17:01:41
By: crosslink-v2
Quality:
67%
✓ SciDEX
ID: experiment-exp-wiki-experiments-lipid-dr
🧫 Experiment Protocol
Clinical
Metadata
| experiment_type | clinical |
| source | {'type': 'manual', 'source_name': 'wiki', 'extraction_date': '2026-04-16T01:00:16.906700Z', 'extracted_by': 'backfill_v1'} |
| entities | {'genes': ['CT'], 'diseases': ["Parkinson's Disease"]} |
| model_system | human |
| summary | # Cytochrome Therapeutics ## Background and Rationale The mitochondrial dysfunction underlying Parkinson's disease represents one of the most compelling therapeutic targets in contemporary neurodegene |
| replication_status | single_study |
| methodology_notes | **Phase 1: Pre-Clinical Validation (Months 1-6)** • Establish primary human dopaminergic neuron cultures from iPSC lines (n=12 PD patient-derived, n=6 healthy controls) • Characterize baseline Complex |
| primary_outcome | Validate Cytochrome Therapeutics |
| extraction_metadata | {'extraction_confidence': 0.4, 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'backfill_at': '2026-04-16T01:00:16.906706'} |
🌍 Provenance Graph
10 nodes, 38 edges
derives from (16)
...and 11 more
Linked Artifacts (5010)